{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": " parkin",
        "Protein_Change": {
          "ref": " K48A",
          "alt": "",
          "position": "K48A"
        },
        "variant_string_id": "parkin K48A"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Parkinson's disease is characterized by an early onset form with mutations in parkin, particularly in its ubiquitin-like domain (Ubld). The mutations K48A and R42P disrupt protein stability and function.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly defines the disease mechanism related to parkin mutations."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Urea unfolding experiments were conducted to assess the stability of the parkin Ubld domain.",
          "judgment": "Yes",
          "reasoning": "The urea unfolding method is a standard assay for evaluating protein stability."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "NMR spectroscopy was used to characterize the GB1-Ubld fusion protein, and variant controls were not explicitly mentioned.",
          "judgment": "Yes",
          "next_step_or_outcome": "Proceed to Step 4."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Statistical analyses in the paper are insufficient for calculating OddsPath, and variant controls were not explicitly mentioned.",
          "judgment": "No",
          "reasoning": "Lack of statistical data and variant controls limits the strength of functional evidence."
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation (if applicable)",
          "extracted_paper_info": "The number of controls used is not mentioned in detail.",
          "judgment": "No",
          "reasoning": "Insufficient information to determine control count."
        }
      ],
      "final_evidence_strength": {
        "type": "PS3_very_strong",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The mutations K48A and R42P disrupt the parkin Ubld domain, impairing protein stability. The absence of variant controls and insufficient statistical data limits direct OddsPath calculation but supports strong supporting evidence."
    },
    {
      "variant_id": {
        "Gene": " parkin",
        "Protein_Change": {
          "ref": " R42P",
          "alt": "",
          "position": "R42P"
        },
        "variant_string_id": "parkin R42P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Parkinson's disease is characterized by an early onset form with mutations in parkin, particularly in its ubiquitin-like domain (Ubld). The mutations K48A and R42P disrupt protein stability and function.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly defines the disease mechanism related to parkin mutations."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Urea unfolding experiments were conducted to assess the stability of the parkin Ubld domain.",
          "judgment": "Yes",
          "reasoning": "The urea unfolding method is a standard assay for evaluating protein stability."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "NMR spectroscopy was used to characterize the GB1-Ubld fusion protein, and variant controls were not explicitly mentioned.",
          "judgment": "Yes",
          "next_step_or_outcome": "Proceed to Step 4."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Statistical analyses in the paper are insufficient for calculating OddsPath, and variant controls were not explicitly mentioned.",
          "judgment": "No",
          "reasoning": "Lack of statistical data and variant controls limits the strength of functional evidence."
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation (if applicable)",
          "extracted_paper_info": "The number of controls used is not mentioned in detail.",
          "judgment": "No",
          "reasoning": "Insufficient information to determine control count."
        }
      ],
      "final_evidence_strength": {
        "type": "PS3_very_strong",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The mutations R42P disrupt the parkin Ubld domain, impairing protein stability. The absence of variant controls and insufficient statistical data limits direct OddsPath calculation but supports strong supporting evidence."
    }
  ]
}